Monte Rosa Therapeutics announces results from MRT-6160, MRT-2359 programs
Monte Rosa announced clinical results from its MRT-6160 Phase 1, single ascending dose / multiple ascending dose study. Details about the ...
Linnaeus Therapeutics Announces Publication of Seminal Paper on LNS8801 in Cancer Research Communications
Linnaeus Therapeutics, Inc. ("Linnaeus"), a privately held biopharmaceutical company focused on the development and ...
News-Medical.Net on MSN11d
Decoding programmed cell death in breast cancer
This review highlights the critical role of ubiquitin-specific proteases (USPs) in regulating programmed cell death (PCD) in breast cancer (BC). As the most prevalent malignant tumor among women, BC ...
News-Medical.Net on MSN14d
Ubiquitination plays a key role in cancer stem cell function and treatment resistance
This review highlights the critical role of ubiquitination in governing the functionality of cancer stem cells (CSCs), shedding light on potential therapeutic targets for combating tumor progression, ...